tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cingulate price target lowered to $16 from $17 at Roth Capital
PremiumThe FlyCingulate price target lowered to $16 from $17 at Roth Capital
3M ago
Cingulate price target lowered to $16 from $17 at Roth Capital
Premium
The Fly
Cingulate price target lowered to $16 from $17 at Roth Capital
3M ago
Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment
Premium
Ratings
Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment
3M ago
Cingulate names Downey as CCO to lead launch prep for CTx-1301
PremiumThe FlyCingulate names Downey as CCO to lead launch prep for CTx-1301
3M ago
Cingulate presents Phase 3 results for CTx-1301, met primary endpoint
Premium
The Fly
Cingulate presents Phase 3 results for CTx-1301, met primary endpoint
3M ago
Strategic Advancements and Partnerships Propel Cingulate Inc. Towards Market Success
Premium
Ratings
Strategic Advancements and Partnerships Propel Cingulate Inc. Towards Market Success
4M ago
Cingulate Inc.’s Strategic Advances and Market Potential Reinforce Buy Rating
PremiumRatingsCingulate Inc.’s Strategic Advances and Market Potential Reinforce Buy Rating
5M ago
Cingulate secures exclusive manufacturing partnership with Bend Bio Sciences
Premium
The Fly
Cingulate secures exclusive manufacturing partnership with Bend Bio Sciences
5M ago
Cingulate Inc Manages Debt with Stock Issuances
Premium
Company Announcements
Cingulate Inc Manages Debt with Stock Issuances
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100